Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 7 of 7 for “"Brand name drugs"”.
-
A web-based survey to assess perceptions of managed care organization representatives regarding the use of co-pay subsidy coupons for prescription drugs
Pharmaceutical manufacturers’ use of prescription brand-name drugs coupons and vouchers to subsidize patients’ cost-sharing obligations such as co-pays has increased. The co-pays are used by managed care organizations (MCOs) to give their plan members an appreciation of drug costs as well as to …
-
Factors Influencing Physicians' Willingness to Substitute Generics For Brand-Names when Prescribing Antimicrobial Drugs
Physicians often continue to prescribe brand-name drugs to their patients even when less expensive generic equivalents are available. In a 1994 study, Judith Hellerstein advances two hypotheses to explain this behavior. First, doctors may consciously conclude that certain brand-name drugs impart a …
-
Statistical aspects of bioavailability
… for this was the excessively high cost of brand name drugs. The substitution of a generic alternative for a brand name drug is based on the assumption that drugs with a comparable chemical composition will have a similar therapeutic effect. The fact that this supposition is not always true …
-
THE EFFECTS OF THE AFFORDABLE CARE ACT ON PHARMACEUTICAL PRICES, DEMAND, AND INNOVATION
… incentivized firms to increase prices for brand-name drugs targeting medical conditions more prevalent among adult workers aged 19 to 64. Specifically, a one standard deviation increase in exposure to these provisions would lead to a 0.079 percent increase in brand-name prices per …
-
Primary care physicians' perspectives on the Ontario Drug Benefit Program (ODB).
… governments to publicly fund prescription drugs when delivered in the hospital. This coverage does not continue once individuals are discharged under the terms of the CHA. Governments do provide additional public coverage for drugs outside of the hospital for specific groups. The Ontario …
-
Essays on Intellectual Property
… of these findings. In the second essay, "Which drugs obtain the Pediatric Exclusivity Provision" we examine the pediatric exclusivity regulation provision. Pediatric exclusivity is designed to reward companies for conducting pediatric trials for dosage and safety with 6 months' extra monopoly on …